Correction: Alternative mammalian target of rapamycin (mTOR) signal activation in sorafenib-resistant hepatocellular carcinoma cells revealed by array-based pathway profiling.

Correction: Alternative mammalian target of rapamycin (mTOR) signal activation in sorafenib-resistant hepatocellular carcinoma cells revealed by array-based pathway profiling.
Mol Cell Proteomics. 2020 Jan;19(1):223
Authors: Masuda M, Chen WY, Miyanaga A, Nakamura Y, Kawasaki K, Sakuma T, Ono M, Chen CL, Honda K, Yamada T
PMID: 31894100 [PubMed - in process]

Source: Molecular and Cellular Proteomics : MCP - December 31, 2019 Category: Molecular Biology Authors: Masuda M, Chen WY, Miyanaga A, Nakamura Y, Kawasaki K, Sakuma T, Ono M, Chen CL, Honda K, Yamada T Tags: Mol Cell Proteomics Source Type: research